REFERENCES
- A Fahr, and X. Liu. (2007). Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv. 4 (4):403–416.
- T. Kennedy. (1997). Managing the drug discovery/development interface. Drug Disc. Today. 2 (10):436–444.
- G Mustata, and SM Dinh. (2006). Approaches to oral drug delivery for challenging molecules. Crit. Rev. Therapeut. Drug Carrier Syst. 23 (2):111–135.
- WL Chiou, and S. Riegelman. (1971). Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (9):1281–1302.
- J Hu, KP Johnston, and RO I WilliamsII. (2004). Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Develop. Industr. Pharm. 30 (3):233–245.
- AM Kaushal, P Gupta, and AK Bansal. (2004). Amorphous drug delivery systems: molecular aspects, design, and performance. Crit. Rev. Ther. Drug Carrier Syst. 21 (3):133–193.
- V Kharb, M Bhatia, H Dureja, and D. Kaushik. (2006). Nanoparticle technology for the delivery of poorly water-soluble drugs. Pharmaceut. Technol. 30 (2):82–92.
- P Kocbek, S Baumgartner, and J. Kristl. (2006). Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int. J. Pharm. 312 (1–2):179–186.
- E Merisko-Liversidge, GG Liversidge, and ER Cooper. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharmaceut. Sci. 18 (2):113–120.
- AT Serajuddin. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (10):1058–1066.
- C Leuner, and J. Dressman. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (1):47–60.
- DA Miller, JT McConville, W Yang, RO WilliamsIII, and JW McGinity. (2007). Hot-melt extrusion for enhanced delivery of drug particles. J. Pharmaceut. Sci. 96 (2):361–376.
- M Vasanthavada, W Tong, Y Joshi, and MS Kislalioglu. (2004). Phase behavior of amorphous molecular dispersion I: determination of the degree and mechanism of solid solubility. Pharm. Res. 21:1598–1606.
- M Vasanthavada, W Tong, Y Joshi, and MS Kislalioglu. (2005). Phase behavior of amorphous molecular dispersion II: role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm. Res. 22:440–448.
- PJ Marsac, SL Shamblin, and LS Taylor. (2006). Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm. Res. 23 (10):2417–2426.
- D Gramaglia, BR Conway, VL Kett, RK Malcolm, and HK Batchelor. (2005). High speed DSC (hyper-DSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix. Int. J. Pharm. 301 (1–2):1–5.
- R Mohan, H Lorenz, and AS Myerson. (2002). Solubility measurement using differential scanning calorimetry. Ind. Eng. Chem. Res. 41:4854–4862.
- A Forster, J Hempenstall, I Tucker, and T. Rades. (2001). Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int. J. Pharm. 226 (1–2):147–161.
- J Li, J Masso, and J. Guertin. (2002). Prediction of drug solubility in an acrylate adhesive based on the drug-polymer interaction parameter and drug solubility in acetonitrile. J. Control Release. 83 (2):211–221.
- MV Margarit, MT Marin, and MD Contreras. (2001). Solubility of solid dispersions of pizotifen malate and povidone. Drug Dev. Ind. Pharm. 27 (6):517–522.
- J Panyam, D Williams, A Dash, D Leslie-Pelecky, and V. Labhasetwar. (2004). Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J. Pharm. Sci. 93 (7):1804–1814.
- TG Fox. (1956). Influence of diluent and of copolymer composition on the glass transition temperature of a polymer system. Bull. Am. Phys. Soc. 1:123.
- E Rytting, KA Lentz, XQ Chen, F Qian, and S. Vakatesh. (2005). Aqueous and cosolvent solubility data for drug-like organic compounds. AAPS. J. 7 (1):E78–105.
- A Nokhodchi, Y Javadzadeh, MR Siahi-Shadbad, and M. Barzegar-Jalali. (2005). The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharm. Sci. 8 (1):18–25.
- A. Martin. Physical Pharmacy. Baltimore, MD: Lippincott Williams & Wilkins; (1993).